Advanced search
Publication Cover
Leukemia & Lymphoma Volume 58, 2017 - Issue 5
Submit an article Journal homepage
260
Views
4
CrossRef citations to date
0
Altmetric
Letters to the Editor

Successful treatment of extranodal natural killer/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis with MEDA chemotherapy

Da-Hui LiDepartment of Hematology, Xin Hua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China;
,
Xiao-Yan ZhangDepartment of Hematology, Xin Jiang People’s Hospital, Xin Jiang, China;
,
Chao DuDepartment of Hematology, Tong Ren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China;
,
Wen-Hao ZhangDepartment of Hematology, Xin Hua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China;
,
Jun ChangDepartment of Hematology, Xin Hua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China;
,
Yu-Jie MaDepartment of Hematology, Xin Hua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China;
,
Zhi-Chao LiDepartment of Hematology, Xin Hua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China;
,
Si-Guo HaoDepartment of Hematology, Xin Hua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China;
,
Hao DingDepartment of Radiation Oncology, Eye and ENT Hospital of Fudan University, Shanghai, ChinaCorrespondence[email protected]
&
Rong TaoDepartment of Hematology, Xin Hua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Correspondence[email protected]
 show all
Pages 1238-1241 | Received 27 Mar 2016, Accepted 16 Aug 2016, Published online: 23 Sep 2016

References

  • Parikh SA, Kapoor P, Letendre L, et al. Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis. Mayo Clin Proc. 2014;89:484–492.
  • Wang Y, Huang W, Hu L, et al. Multicenter study of combination DEP regimen as a salvage therapy for adult refractory hemophagocytic lymphohistiocytosis. Blood. 2015;126:2186–2192.
  • Han AR, Lee HR, Park BB, et al. Lymphoma-associated hemophagocytic syndrome: clinical features and treatment outcome. Ann Hematol. 2007;86:493–498.
  • Takahashi N, Miura I, Chubachi A, et al. A clinicopathological study of 20 patients with T/natural killer (NK)-cell lymphoma-associated hemophagocytic syndrome with special reference to nasal and nasal-type NK/T-cell lymphoma. Int J Hematol. 2001;74:303–308.
  • Tong H, Ren Y, Liu H, et al. Clinical characteristics of T-cell lymphoma associated with hemophagocytic syndrome: comparison of T-cell lymphoma with and without hemophagocytic syndrome. Leuk Lymphoma. 2008;49:81–87.
  • Jaccard A, Gachard N, Marin B, et al. Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study. Blood. 2011;117:1834–1839.
  • Kwong YL, Kim WS, Lim ST, et al. SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group. Blood. 2012;120:2973–2980.
  • Yamaguchi M, Kwong YL, Kim WS, et al. Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study. J Clin Oncol. 2011;29:4410–4416.
  • Ding H, Chang J, Liu LG, et al. High-dose methotrexate, etoposide, dexamethasone and pegaspargase (MEDA) combination chemotherapy is effective for advanced and relapsed/refractory extranodal natural killer/T cell lymphoma: a retrospective study. Int J Hematol. 2015;102:181–187.
  • Kushner BH, LaQuaglia MP, Wollner N, et al. Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy. J Clin Oncol. 1996;14:1526–1531.
  • Marsh RA, Allen CE, McClain KL, et al. Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab. Pediatr Blood Cancer. 2013;60:101–109.
  • Inoue D, Nagai Y, Takiuchi Y, et al. Successful treatment of extranodal natural killer/T-cell lymphoma, nasal type, complicated by severe hemophagocytic syndrome, with dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide chemotherapy followed by autologous stem cell transpl. Leuk Lymphoma. 2010;51:720–723.
  • Teramura T, Tabata Y, Yagi T, et al. Quantitative analysis of cell-free Epstein-Barr virus genome copy number in patients with EBV-associated hemophagocytic lymphohistiocytosis. Leuk Lymphoma. 2002;43:173–179.
  • Lee J, Au WY, Park MJ, et al. Autologous hematopoietic stem cell transplantation in extranodal natural killer/T cell lymphoma: a multinational, multicenter, matched controlled study. Biol Blood Marrow Transplant. 2008;14:1356–1364.
  • Yhim HY, Kim JS, Mun YC, et al. Clinical outcomes and prognostic factors of up-front autologous stem cell transplantation in patients with extranodal natural killer/T cell lymphoma. Biol Blood Marrow Transplant. 2015;21:1597–1604.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.